Grenoble Cedex 9

• Efficacy of probenecid on cluster seizures during dosage reduction of Anti Seizure Medication (ASM) in presurgical focal epilepsy video-EEG … Pending
  2024-519133-29-00 4 Focal epilepsy
• Efficacy of non operative treatment with amoxicillin/clavulanic acid versus surgical treatment in acute uncomplicated appendicitis in childr … Pending
  2024-519402-12-00 5 uncomplicated appendicitis
• A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have compl … Pending
  2024-519638-22-00 5 IgA nephropathy
• PRODIGE 104 – NEOPREDICT A multicenter phase II trial using transcriptomic signatures to personalize neoadjuvant chemotherapy for patients … Pending
  2024-519753-11-00 4 Resectable borderline pancreatic adenocarcinoma
• Early optimization of ceftazidine dosing regimen in critical care : FORTOPTIM_1 Pending
  2024-519783-41-00 4 sepsis
• RIFAMAB : Rifabutin versus rifampicin, staphylococcal prosthetic joint infection, multicenter randomized, open-label, non-inferiority trial Pending
  2024-519894-20-01 5 Adult with an staphylococcal prosthetic joint infection treated with d
• Effect of H2 inhalation therapy on early recurrence after atrial fibrillation ablation. Pending
  2024-520131-33-00 4 atrial fibrillation
• “Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A Multicen … Pending
  2024-520414-21-00 5 Adult patients with a LVOS with large core within 9 hours of symptoms
• OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending
  2025-520554-11-00 5 Cardiovascular Disease
• Efficiency of a composite personalised care on functional outcome in early psychosis: A Prospective Randomised Controlled Trial Pending
  2025-520573-39-00 6 Ultra High Risk of psychosis and first episode psychosis
• Optimal Duration of Antibiotic Therapy in Drained Pyogenic Liver Abscess: 3 weeks versus 6 weeks, a non-inferiority trial Pending
  2025-520940-14-00 6 Pyogenic liver abscess
• A multicenter phase 2 study of Belantamab mafodotin and Mezigdomide in combination with a phase Ib Safety run in patients with relapsed mult … Pending
  2025-520976-25-00 4 Relapsed/refractory multiple myeloma
• A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s disease Pending
  2025-521037-86-00 5 Immune system diseases
• A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active ulcerative coliti … Pending
  2025-521038-27-00 5 Immune system diseases
• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease Pending
  2025-521113-13-00 10 Early Parkinson’s Disease
• Study PACIFIC: Fixed duration treatment with combined pirtobrutinib and short course immuno-chemotherapy in fit patients with previously unt … Pending
  2025-521199-80-00 4 Patients with previously untreated symptomatic chronic lymphocytic leu
• FILO-AML-01-MIVONU A single arm phase II study investigating the efficacy and safety of the addition of ivosidenib to oral azacitidine (Onur … Pending
  2025-521322-14-00 4 Patients over 55 with Acute Myeloid Leukemia (AML) and IDH1 mutation,
• Phase II study of ficerafusp alfa in combination with nivolumab in patients with platinum-refractory head and neck squamous cell carcinoma w … Pending
  2025-521437-88-00 4 head and neck squamous cell carcinoma
• ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITIS Pending
  2025-521478-32-00 5 PEDIATRIC ACUTE MYOCARDITIS
• PREV-CART - “A multicentric phase III randomized clinical trial open-label, comparing immunoglobulin replacement therapy (IgRT) and antibiot … Pending
  2025-521571-30-00 5 Young Adults and adults with R/R B-cell acute lymphoblastic leukemia (
• Study evaluating two treatment strategies for rectal cancer in patients ≥75 years old Pending
  2025-521619-37-00 5 Patients ≥75 years old with cT3/T4 rectal adenocarcinoma eligible to r
• Etude de phase II évaluant la capacité d'un agoniste des récepteurs 5-HT4, le prucalopride (Resolor©), à accélérer l'efficacité thérapeutiqu … Pending
  2025-521811-38-01 4 Dépression
• Phase 3 Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Platinum Resistant Ovarian Cancer With Cyclin E1 Overexpression Pending
  2025-522748-42-00 5 Ovarian cancer
• Trial assessing treatment in patients with advanced Lung Cancer and Interstitial Lung Disease Pending
  2025-522790-10-00 4 Non Small Cell Lung Cancer

Showing 25–48 of 563 trials